Improves skin health and coat quality
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinsons disease after peripheral administration
Researchers at University of California San Diego School of Medicine have reported results from a large international clinical trial showing that semaglutide, a medication in the GLP-1 class of drugs widely used to treat diabetes and obesity, may help reduce liver scarring in patients with advanced fatty liver disease, including those with early-stage cirrhosis
By improving insulin sensitivity and lowering glucose levels, semaglutide helps your body stabilize its energy production, which can reduce cravings for sugary or high-calorie foods
These headaches are often temporary and tend to resolve as the body becomes accustomed to the medication
Metabolicinflammatory burden predicts mortality in heart failure across population and ICU cohorts, International Journal of Cardiology Cardiovascular Risk and Prevention, 30 , (200648), (2026)